Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunction

Neurourology and Urodynamics

Volumn 15, Issue 2, 1996, Pages 119-131

  Perrigot, Michel ^a   Delauche Cavallier, Marie C ^b,d   Amarenco, Gérard ^b   Geffriaud, Christine ^b   Stalla Bourdillon, Aline ^b   Costa, Pierre ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre Hospitalier Robert Ballanger CHRB   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d SANOFI   (France)

Author keywords

alfuzosin; alpha one blockers; neurogenic bladder; urodynamics

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; BLADDER DYSFUNCTION; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NEUROGENIC BLADDER; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; SPINAL CORD INJURY; URETHRA PRESSURE; VERTIGO;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PRESSURE; QUINAZOLINES; URETHRA; URINARY BLADDER, NEUROGENIC; URODYNAMICS;

EID: 0030005670     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.1930150203     Document Type: Article

References (33)

1. Awad SA, Downie JW, Lywood DW, Young RA, Jarzylo SV (1976): Sympathetic activity in the proximal urethra in patients with urinary obstruction. J Urol 115:545-547.
2. Blaivas JG, Sinha HP, Zayed AAH, Labib KB (1981): Detrusor-external sphincter dyssynergia. J Urol 125:542-544.
3. Buczynski AZ (1984): Urodynamic studies in evaluating detrusor sphincter dyssynergia and their effects on the treatment. Paraplegia 22:168-172.
4. 1-adrenoceptor antagonist effects of alfuzosin in rabbit and dog lower urinary tract. Br J Pharmacol 86:416P.
5. Chancellor MB, Erhard MJ, Hirsch IM, Stass WE (1993): Prospective evaluation of terazosin for the treatment of anatomic dysreflexia. J Urol 151:111-113.
6. Costa P, Bressole F, Sarrazin B, Mosser J, Sabatier R (1993): Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries. Clin Pharmacol Ther 53:443-449.
7. Cramer P, Neveux E, Régnier F, Depassio J, Bérard R (1989): Bladder-neck opening test in spinal cord injury patients using a new i.v. alpha-blocking agent, alfuzosin. Paraplegia 27:119-124.
8. Delauche-Cavallier MC, Richard JM, Buzelin M, Leriche P, Attali P, Jardin A (1993): Alpha-blocker therapy with alfuzosin in neurogenic bladder disease. Neurourol Urodyn 12:24A.
9. Hachen HJ (1980): Clinical and urodynamic assessment of alpha-adrenolytic therapy in patients with neurogenic bladder function. Paraplegia 18:229-238.
10. Harrison NW, Whitfield HN, Williams DI (1977): The place of ex-blocking drugs in the treatment of children with neuropathic bladders. Urol Int 32:224-231.
11. Hommel G (1988): A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 75:383-386.
12. Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P, the BPH-ALF Group (1991): Alfuzosin for treatment of benign prostatic hypertrophy. Lancet 337:1457-1461.
13. Jardin A, Bensadoun H, Delauche-Cavallier MC, Attali P, the BPH-ALF Group (1993): Long term treatment of benign prostatic hypertrophy with alfuzosin: A 12-18 month assessment. Br J Urol 72:615-620.
14. Kleeman FJ (1970): The physiology of internal urinary sphincter. J Urol 104:549-554.
15. Krane RJ, Olsson CA (1973): Phenoxybenzamine in neurogenic bladder dysfunction. I. A theory of micturition. II. Clinical considerations. J Urol 110:650-652.
16. Lefevre-Borg F, Lechaire J, O'Connors S (1992): In vivo uroselectivity of alfuzosin compared to prazosin and terazosin. Br J Pharmacol 106:(Suppl):84P.
17. 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 109:1282-1289.
18. Light JK, Beric A (1992): Detrusor function in suprasacral cord injuries. J Urol 148:355-358.
19. Martorana G, Gilberti C, di Silverio F, von Heland M, Rigatti P, Colombo R, Casadei G, Pacifico P (1995): Urodynamic assessment of alfuzosin effect on bladder outflow obstruction in benign prostatic hyperplasia. J Urol 153:185A.
20. McGuire EJ (1986): The innervation and function of the lower urinary tract. J Neurosurg 65:278-285.
21. Nanninga JB, Kaplan P, Lal S (1977): Effect of phentolamine on perineal muscle EMG activity in paraplegia. Br J Urol 49:537-539.
22. Nording J (1978): Alpha-blockers and urethral pressure in neurological patients. Urol Int 33:304-309.
23. Olsson CA, Siroky MB, Krane RJ (1977): The phentolamine test in neurogenic bladder dysfunction. J Urol 117:481-485.
24. Pedersen E, Torring J, Klemar B (1980): Effect of alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. Acta Neurol Scand 61:107-114.
25. Perrigot M, Vannier A, Ber Y (1986): Les alpha-bloquants dans les troubles vésico-sphinctériens. Rev Prat 36:223-228.
26. Perrigot M, Amarenco G, Chatelain C (1987): Place des traitements medicamenteux dans la rééducation des troubles vésico-sphinctériens de la sclérose en plaques. In Masson (ed): "Scléroses en Plaques et Médecine de Rééducation," Vol 1. Paris: pp 68-77.
27. Petersen T, Husted SE, Sidenius P (1989): Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability. Scand J Urol Nephrol 23:189-194.
28. Schuren B, Yasuda K, Rossier AB (1994): Detrusor bladder neck dyssynergia revisited. J Urol 152:2066-2070.
29. Scott MB, Morrow JW (1978): Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. I. Voiding dysfunction. J Urol 119:480-482.
30. Swierzewski SJ, Gormley EA, Belville WD, Sweetser PM, Wan J, McGuire EJ (1994): The effect of terazosin on bladder function in the spinal cord injured patient. J Urol 151:951-954.
31. Vaiddyanathan S, Rao MS, Sharma PL, Sachdeva NK (1983): Significance of alpha-1 adrenergic innervation of the urinary bladder in human neurogenic vesical dysfunction. Indian J Med Res 77:529-533.
32. Wilde M, Fitton A, McTavish D (1993): Alfuzosin: A review of its pharmacodynamic and phannacokinetic properties, and therapeutic potential in benign prostatic hypertrophy. Drugs 45:410-429.
33. Yalla SV, Rossier AB, Fam BA, Gabilondo FB, Di Benedetto M, Gittes RF (1977): Functional contribution of autonomic innervation to urethral striated sphincter: Studies with parasympathomimetic, parasympatholytic and alpha-adrenergic blocking agents in spinal cord injury and control male subjects. J Urol 117:494-499.